Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies

Clinical Nutrition

Volumn 35, Issue 6, 2016, Pages 1269-1281

  Marventano, Stefano ^a   Salomone, Federico ^b   Godos, Justyna ^c   Pluchinotta, Francesca ^d   Del Rio, Daniele ^e   Mistretta, Antonio ^a   Grosso, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Azienda Sanitaria Provinciale di Catania   (Italy)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

Author keywords

Coffee; Meta analysis; Metabolic syndrome; NAFLD; Tea

Indexed keywords

ARTICLE; COFFEE; DISEASE SEVERITY; FOOD INTAKE; HUMAN; LIVER FIBROSIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; SYSTEMATIC REVIEW; TEA; DIET; LIVER CIRRHOSIS; MEDLINE; META ANALYSIS; ODDS RATIO;

CAFFEINE;

CAFFEINE; COFFEE; DIET; HUMANS; LIVER CIRRHOSIS; MEDLINE; METABOLIC SYNDROME; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; TEA;

EID: 84962339204     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2016.03.012     Document Type: Article

References (48)

1. [1] Loomba, R., Sanyal, A.J., The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10 (2013), 686–690, 10.1038/nrgastro.2013.171.
2. [2] Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., Loria, P., Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis 47 (2015), 181–190, 10.1016/j.dld.2014.09.020.
3. [3] Polimeni, L., Del Ben, M., Baratta, F., Perri, L., Albanese, F., Pastori, D., et al. Oxidative stress: new insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World J Hepatol 7 (2015), 1325–1336, 10.4254/wjh.v7.i10.1325.
4. [4] Salamone, F., Bugianesi, E., Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome. J Hepatol 53 (2010), 1146–1147, 10.1016/j.jhep.2010.06.013.
5. [5] Zelber-Sagi, S., Ratziu, V., Oren, R., Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 17 (2011), 3377–3389, 10.3748/wjg.v17.i29.3377.
6. [6] Buscemi, S., Nicolucci, A., Mattina, A., Rosafio, G., Massenti, F.M., Lucisano, G., et al. Association of dietary patterns with insulin resistance and clinically silent carotid atherosclerosis in apparently healthy people. Eur J Clin Nutr 67 (2013), 1284–1290, 10.1038/ejcn.2013.172.
7. [7] Buscemi, S., Sprini, D., Grosso, G., Galvano, F., Nicolucci, A., Lucisano, G., et al. Impact of lifestyle on metabolic syndrome in apparently healthy people. Eat Weight Disord 19 (2014), 225–232, 10.1007/s40519-014-0117-4.
8. [8] Grosso, G., Mistretta, A., Marventano, S., Purrello, A., Vitaglione, P., Calabrese, G., et al. Beneficial effects of the Mediterranean diet on metabolic syndrome. Curr Pharm Des 20 (2014), 5039–5044.
9. [9] Jin, X., Zheng, R.H., Li, Y.M., Green tea consumption and liver disease: a systematic review. Liver Int 28 (2008), 990–996, 10.1111/j.1478-3231.2008.01776.x.
10. [10] Saab, S., Mallam, D., Cox, G.A. 2nd, Tong, M.J., Impact of coffee on liver diseases: a systematic review. Liver Int 34 (2014), 495–504, 10.1111/liv.12304.
11. [11] Wells, G.A.S.B., O'Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 1999, Ottawa Health Research Institute, Ottawa (Canada).
12. [12] Zelber-Sagi, S., Salomone, F., Webb, M., Lotan, R., Yeshua, H., Halpern, Z., et al. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Transl Res 165 (2015), 428–436, 10.1016/j.trsl.2014.10.008.
13. [13] Gutierrez-Grobe, Y., Chavez-Tapia, N., Sanchez-Valle, V., Gavilanes-Espinar, J.G., Ponciano-Rodriguez, G., Uribe, M., et al. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity. Ann Hepatol 11 (2012), 350–355.
14. [14] Molloy, J.W., Calcagno, C.J., Williams, C.D., Jones, F.J., Torres, D.M., Harrison, S.A., Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 55 (2012), 429–436, 10.1002/hep.24731.
15. [15] Birerdinc, A., Stepanova, M., Pawloski, L., Younossi, Z.M., Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 35 (2012), 76–82, 10.1111/j.1365-2036.2011.04916.x.
16. [16] Catalano, D., Martines, G.F., Tonzuso, A., Pirri, C., Trovato, F.M., Trovato, G.M., Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 55 (2010), 3200–3206, 10.1007/s10620-010-1143-3.
17. [17] Anty, R., Marjoux, S., Iannelli, A., Patouraux, S., Schneck, A.S., Bonnafous, S., et al. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 57 (2012), 1090–1096, 10.1016/j.jhep.2012.07.014.
18. [18] Bambha, K., Wilson, L.A., Unalp, A., Loomba, R., Neuschwander-Tetri, B.A., Brunt, E.M., et al. Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver Int 34 (2014), 1250–1258, 10.1111/liv.12379.
19. [19] Kim, H.J., Cho, S., Jacobs, D.R. Jr., Park, K., Instant coffee consumption may be associated with higher risk of metabolic syndrome in Korean adults. Diabetes Res Clin Pract 106 (2014), 145–153, 10.1016/j.diabres.2014.07.007.
20. [20] Matsuura, H., Mure, K., Nishio, N., Kitano, N., Nagai, N., Takeshita, T., Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol 22 (2012), 160–166.
21. [21] Driessen, M.T., Koppes, L.L., Veldhuis, L., Samoocha, D., Twisk, J.W., Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr 63 (2009), 536–542, 10.1038/ejcn.2008.6.
22. [22] Dos Santos, P.R., Ferrari, G.S., Ferrari, C.K., Diet, sleep and metabolic syndrome among a legal Amazon population. Braz Clin Nutr Res 4 (2015), 41–45, 10.7762/cnr.2015.4.1.41.
23. [23] Wilsgaard, T., Jacobsen, B.K., Lifestyle factors and incident metabolic syndrome. The Tromso Study 1979-2001. Diabetes Res Clin Pract 78 (2007), 217–224, 10.1016/j.diabres.2007.03.006.
24. [24] Yen, A.M., Chiu, Y.H., Chen, L.S., Wu, H.M., Huang, C.C., Boucher, B.J., et al. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am J Clin Nutr 83 (2006), 1153–1160.
25. [25] Nordestgaard, A.T., Thomsen, M., Nordestgaard, B.G., Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol 44 (2015), 551–565, 10.1093/ije/dyv083.
26. [26] Lutsey, P.L., Steffen, L.M., Stevens, J., Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 117 (2008), 754–761, 10.1161/CIRCULATIONAHA.107.716159.
27. [27] Takami, H., Nakamoto, M., Uemura, H., Katsuura, S., Yamaguchi, M., Hiyoshi, M., et al. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) study in Tokushima, Japan. J Epidemiol 23 (2013), 12–20.
28. [28] Grosso, G., Marventano, S., Galvano, F., Pajak, A., Mistretta, A., Factors associated with metabolic syndrome in a Mediterranean population: role of caffeinated beverages. J Epidemiol 24 (2014), 327–333.
29. [29] Grosso, G., Stepaniak, U., Micek, A., Topor-Madry, R., Pikhart, H., Szafraniec, K., et al. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr 54 (2015), 1129–1137, 10.1007/s00394-014-0789-6.
30. [30] Chang, C.S., Chang, Y.F., Liu, P.Y., Chen, C.Y., Tsai, Y.S., Wu, C.H., Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao old people (TOP) study 02. PLoS One, 7, 2012, e38874, 10.1371/journal.pone.0038874.
31. [31] Wan, C.J., Lin, L.Y., Yu, T.H., Sheu, W.H., Metabolic syndrome associated with habitual indulgence and dietary behavior in middle-aged health-care professionals. J Diabetes Investig 1 (2010), 259–265, 10.1111/j.2040-1124.2010.00055.x.
32. [32] Hino, A., Adachi, H., Enomoto, M., Furuki, K., Shigetoh, Y., Ohtsuka, M., et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 76 (2007), 383–389, 10.1016/j.diabres.2006.09.033.
33. [33] Yu, S., Guo, X., Yang, H., Zheng, L., Sun, Y., An update on the prevalence of metabolic syndrome and its associated factors in rural northeast China. BMC Public Health, 14, 2014, 877, 10.1186/1471-2458-14-877.
34. [34] Zuo, H., Shi, Z., Hu, X., Wu, M., Guo, Z., Hussain, A., Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism 58 (2009), 1102–1108, 10.1016/j.metabol.2009.04.008.
35. [35] Chen, S., Teoh, N.C., Chitturi, S., Farrell, G.C., Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?. J Gastroenterol Hepatol 29 (2014), 435–441, 10.1111/jgh.12422.
36. [36] Salomone, F., Godos, J., Zelber-Sagi, S., Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives. Liver Int 36 (2015), 5–20, 10.1111/liv.12975.
37. [37] Vitaglione, P., Morisco, F., Mazzone, G., Amoruso, D.C., Ribecco, M.T., Romano, A., et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 52 (2010), 1652–1661, 10.1002/hep.23902.
38. [38] Suzuki, Y., Miyoshi, N., Isemura, M., Health-promoting effects of green tea. Proc Jpn Acad Ser B Phys Biol Sci 88 (2012), 88–101.
39. [39] Buscemi, S., Marventano, S., Antoci, M., Cagnetti, A., Castorina, G., Galvano, F., et al. Coffee and metabolic impairment: an updated review of epidemiological studies. NFS J 3 (2016), 1–7, 10.1016/j.nfs.2016.02.001.
40. [40] Grosso, G., Stepaniak, U., Topor-Madry, R., Szafraniec, K., Pajak, A., Estimated dietary intake and major food sources of polyphenols in the Polish arm of the HAPIEE study. Nutrition 30 (2014), 1398–1403, 10.1016/j.nut.2014.04.012.
41. [41] Acheson, K.J., Gremaud, G., Meirim, I., Montigon, F., Krebs, Y., Fay, L.B., et al. Metabolic effects of caffeine in humans: lipid oxidation or futile cycling?. Am J Clin Nutr 79 (2004), 40–46.
42. [42] Steffen, M., Kuhle, C., Hensrud, D., Erwin, P.J., Murad, M.H., The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens 30 (2012), 2245–2254, 10.1097/HJH.0b013e3283588d73.
43. [43] Onakpoya, I., Spencer, E., Heneghan, C., Thompson, M., The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 24 (2014), 823–836, 10.1016/j.numecd.2014.01.016.
44. [44] Godos, J., Pluchinotta, F.R., Marventano, S., Buscemi, S., Li Volti, G., Galvano, F., et al. Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr 65 (2014), 925–936, 10.3109/09637486.2014.940287.
45. [45] Grosso, G., Stepaniak, U., Polak, M., Micek, A., Topor-Madry, R., Stefler, D., et al. Coffee consumption and risk of hypertension in the Polish arm of the HAPIEE cohort study. Eur J Clin Nutr 70 (2015), 109–115, 10.1038/ejcn.2015.119.
46. [46] Cai, L., Ma, D., Zhang, Y., Liu, Z., Wang, P., The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 66 (2012), 872–877, 10.1038/ejcn.2012.68.
47. [47] Bursill, C.A., Abbey, M., Roach, P.D., A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193 (2007), 86–93, 10.1016/j.atherosclerosis.2006.08.033.
48. [48] Jiang, X., Zhang, D., Jiang, W., Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 53 (2014), 25–38, 10.1007/s00394-013-0603-x.